Company / Operating Income
IRADIMED CORP Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$26.1M
FY2025
5-year range
$8.6M / $26.1M
FY2021-FY2025
Trend
+19.0%
vs FY2024
Sector context
#95 of 156
Health Care
What the data says
At $26M, IRADIMED CORP's operating income ranks #95 of 156 in the Health Care sector. Operating Income has increased for 5 consecutive years, from -$756,091 in FY2020 to $26M in FY2025.
Based on SEC 10-K filings.
$26M in FY2025 with a 3-year CAGR of +38.6%.
Improved from $20M to $26M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- +38.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#95 of 156 in Health CareTop 61% of 156This company $26.1M Sector average $733.1M
▼
-96.4% below sector average
Key checks
Key Insights
- IRADIMED CORP's operating income has grown for 5 consecutive years.
- 3-year CAGR of +38.6%, indicating consistent growth.
- In FY2025, operating income increased 19.0% year-over-year.
- Ranks #95 out of 156 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 5.29 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $26.1M | +19.0% |
| FY2024 | $22.0M | +9.6% |
| FY2023 | $20.0M | +104.1% |
| FY2022 | $9.8M | +13.5% |
| FY2021 | $8.6M | +1243.7% |
| FY2020 | -$756.1K | -108.7% |
| FY2019 | $8.6M | -20.8% |
| FY2018 | $10.9M | -5.2% |
| FY2017 | $11.5M | +275.5% |
| FY2016 | $3.1M | +0.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026